Laurent Fischer Adverum Biotechnologies, Inc. (ADVM) insider trading activity

Laurent Fischer is CEO, PRESIDENT AND DIRECTOR of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 0 shares of ADVM, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2025, when has been sold 25,000 shares (Common Stock - Restricted Stock Units) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Laurent Fischer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	25,000 Reduced 100.0%	0 Common Stock - Restric...
Dec 09 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	351,513 Reduced 100.0%	0 Common Stock
Dec 09 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	522,666 Reduced 100.0%	0 Common Stock - Perform...
Dec 09 2025	BUY Exercise of conversion of derivative security	$630,000 $4.2 p/Share	150,000 Added 29.91%	351,513 Common Stock
Dec 09 2025	BUY Grant, award, or other acquisition	-	500,000 Added 48.89%	522,666 Common Stock - Perform...
Dec 08 2025	BUY Open market or private purchase	$506,916 $4.31 p/Share	117,614 Added 36.85%	201,513 Common Stock
Dec 05 2025	BUY Open market or private purchase	$47,000 $4.24 p/Share	11,085 Added 11.67%	83,899 Common Stock

May 15 2025	SELL Open market or private sale	$18,252 $2.0 p/Share	9,126 Reduced 9.45%	87,488 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	25,000 Added 20.56%	96,614 Common Stock
Mar 15 2023	SELL Open market or private sale	$32,166 $0.78 p/Share	41,239 Reduced 5.62%	692,141 Common Stock
Sep 19 2022	SELL Open market or private sale	$43,958 $1.07 p/Share	41,082 Reduced 5.35%	727,380 Common Stock
Apr 20 2022	BUY Open market or private purchase	$27,750 $1.11 p/Share	25,000 Added 3.17%	762,462 Common Stock
Dec 09 2021	BUY Open market or private purchase	$26,498 $1.85 p/Share	14,323 Added 1.91%	737,462 Common Stock
Dec 08 2021	BUY Open market or private purchase	$19,112 $1.79 p/Share	10,677 Added 1.45%	723,139 Common Stock
Aug 06 2021	BUY Grant, award, or other acquisition	-	680,000 Added 49.05%	706,292 Common Stock
Mar 24 2021	BUY Open market or private purchase	$98,800 $9.88 p/Share	10,000 Added 27.55%	26,292 Common Stock
Jan 15 2021	BUY Open market or private purchase	$99,158 $11.53 p/Share	8,600 Added 34.55%	16,292 Common Stock

Also insider at

CTIC

CTI BIOPHARMA CORP Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

ATAI

ATAI Life Sciences N.V. Healthcare

Laurent Fischer

CEO, PRESIDENT AND DIRECTOR

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Value

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM

Account